Emergent, DoD Amend Contract
June 27, 2007, 2:38PM
© 2007 The Associated Press
http://www.chron.com/disp/story.mpl/ap/fn/4925370.html
ROCKVILLE, Md. — Biopharmaceutical company Emergent BioSolutions Inc. on
Wednesday said it will accelerate delivery of its BioThrax anthrax vaccine to
the Department of Defense.
The company said it expects $20 million in revenue in the second quarter due to
the amended agreement with the Defense Department to accelerates delivery of its
Biothrax vaccine.
Emergent will deliver 900,000 doses of the vaccine during the quarter ending
June 30 or shortly after that.
Emergent said it is also preparing a response to a proposal request from the
Department of Defense for a follow-on contract to supply up to 14 million doses
of BioThrax to the military. The one-year contract has three option years.
Shares rose 41 cents, or 4.4 percent, to $9.80 during afternoon trading. The
stock has traded between $8.33 and $17.75 during the past 52 weeks.
____________
Questions or comments about this story should be directed to the Financial News
desk of The Associated Press at 212-621-7190.